FeNO is not affected by spirometry, IOS or walking in healthy subjects or well controlled asthma patients

H. Andersen (Aarhus, Denmark), L. Pedersen (Aarhus, Denmark), M. Mousa (Aarhus, Denmark), N. Mousa (Aarhus, Denmark), A. Bjerrum (Aarhus, Denmark), T. Skjold (Aarhus, Denmark), T. Smidt-Hansen (Aarhus, Denmark), H. Hoffmann (Aarhus, Denmark), J. Schmid (Aarhus, Denmark)

Source: International Congress 2022 – Allergy and asthma: biomarkers, phenotypes and real-world evidence

Session: Allergy and asthma: biomarkers, phenotypes and real-world evidence
Session type: Thematic Poster
Number: 1684

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Andersen (Aarhus, Denmark), L. Pedersen (Aarhus, Denmark), M. Mousa (Aarhus, Denmark), N. Mousa (Aarhus, Denmark), A. Bjerrum (Aarhus, Denmark), T. Skjold (Aarhus, Denmark), T. Smidt-Hansen (Aarhus, Denmark), H. Hoffmann (Aarhus, Denmark), J. Schmid (Aarhus, Denmark). FeNO is not affected by spirometry, IOS or walking in healthy subjects or well controlled asthma patients. 1684

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.